Why is IFF announcing a $2.5 billion buyback now?

IFF is executing a portfolio transformation that includes divesting its Food Ingredients business to CVC Capital Partners. The company expects to receive approximately $3.8 billion in net proceeds. Rather than deploy all proceeds to debt reduction alone, IFF is using the divestiture to fund both debt paydown (over $1 billion) and share repurchases, signaling confidence in long-term value creation at current valuations and demonstrating balanced capital discipline.

What is an accelerated share repurchase (ASR) and why execute $500M in H2 2026?

An ASR allows a company to repurchase a large volume of shares upfront from an investment bank, with settlement and pricing finalized over time based on the bank's open-market purchases. IFF's $500 million ASR in H2 2026 demonstrates confidence in near-term valuation and allows the company to execute a material buyback before closing the Food Ingredients sale, which is expected by end of Q2 2027.

How will IFF fund the repurchase program?

The company plans to fund repurchases from three sources: cash provided by operating activities, short-term debt, and net cash proceeds from the Food Ingredients divestiture sale. The $500 million ASR in H2 2026 may utilize operating cash flow and short-term debt, while the remaining $2.0 billion is expected to be funded primarily from divestiture proceeds following the sale close.

How does the buyback fit into IFF's balance sheet strategy?

IFF intends to maintain a strong balance sheet with net leverage of 2.0x to 2.5x net debt to EBITDA. The company will prioritize debt reduction with over $1 billion of divestiture proceeds before allocating remaining proceeds to share repurchases. This two-pronged approach balances shareholder returns with financial flexibility and deleveraging from the company's current net debt position of approximately $5.2 billion as of June 30, 2026.

When will the full $2.5 billion repurchase be completed?

The $500 million ASR is planned for H2 2026. The remaining $2.0 billion will commence after the Food Ingredients divestiture closes, expected by end of Q2 2027, with the entire program targeted for completion by the end of 2027. The Board will review the program periodically and may adjust its term and size as needed.

What percentage of IFF's shares could be repurchased under this authorization?

Based on Q2 2026 average diluted shares outstanding of 257 million, the $2.5 billion program could retire approximately 1–2% of shares outstanding, depending on execution price and market conditions. The actual share reduction will depend on the average price paid per share during the execution period over the next 18 months.

IFF 8-K Filed 2026-08-04 New authorization

IFF authorizes enhanced $2.5B share repurchase program

$500M ASR planned for H2 2026; remaining $2.0B to execute post-divestiture close by end of 2027

Authorization$2.5B

MechanismAccelerated Share Repurchase

What the filing says

International Flavors & Fragrances Inc. announced on August 4, 2026, that its Board of Directors has authorized an enhanced share repurchase program valued at $2.5 billion, which includes approximately $400 million remaining from a prior authorization. The new program reflects IFF's confidence in long-term value creation and the attractive return profile of repurchases at current valuation levels, according to CEO Erik Fyrwald.

The company plans to execute $500 million of the authorization as an accelerated share repurchase (ASR) in the second half of 2026. The remaining $2.0 billion is expected to be executed following the close of the pending Food Ingredients business divestiture to CVC Capital Partners, with completion of the full program targeted by the end of 2027. IFF plans to fund repurchases from operating cash flow, short-term debt, and net cash proceeds from the Food Ingredients divestiture, which is expected to generate approximately $3.8 billion in net proceeds.

The authorization reflects a disciplined capital allocation strategy. Following the Food Ingredients sale close, IFF intends to apply net proceeds to reduce outstanding debt by over $1 billion while maintaining financial flexibility with leverage in the range of 2.0x to 2.5x net debt to EBITDA. The Board will review the share repurchase program periodically and may authorize adjustments to its term and size.

The Board has also authorized an enhanced $2.5 billion share repurchase program, beginning with $500 million to be executed in the second half of 2026, reflecting our confidence in IFF's long-term value creation opportunity and the compelling return profile of repurchases at current valuation levels. We expect to execute the remaining $2.0 billion of the authorization following the anticipated transaction close, with completion of this repurchase program targeted by the end of 2027. — INTERNATIONAL FLAVORS & FRAGRANCES INC 8-K filing · View on SEC EDGAR →

What this means

IFF's $2.5 billion authorization is part of a sequenced capital allocation plan tied to the company's portfolio transformation, including the divestiture of its Food Ingredients business. The immediate $500 million ASR signals management's confidence in valuation at the time of announcement. The remaining $2.0 billion execution is contingent on the Food Ingredients sale close and will be funded partially from divestiture proceeds. With an average of 257 million diluted shares outstanding in the second quarter, the full $2.5 billion program could represent approximately 1% to 2% of current market capitalization depending on execution price, though actual impact will depend on market conditions and execution timing over the next 18 months.

Frequently asked questions

Why is IFF announcing a $2.5 billion buyback now?: IFF is executing a portfolio transformation that includes divesting its Food Ingredients business to CVC Capital Partners. The company expects to receive approximately $3.8 billion in net proceeds. Rather than deploy all proceeds to debt reduction alone, IFF is using the divestiture to fund both debt paydown (over $1 billion) and share repurchases, signaling confidence in long-term value creation at current valuations and demonstrating balanced capital discipline.
What is an accelerated share repurchase (ASR) and why execute $500M in H2 2026?: An ASR allows a company to repurchase a large volume of shares upfront from an investment bank, with settlement and pricing finalized over time based on the bank's open-market purchases. IFF's $500 million ASR in H2 2026 demonstrates confidence in near-term valuation and allows the company to execute a material buyback before closing the Food Ingredients sale, which is expected by end of Q2 2027.
How will IFF fund the repurchase program?: The company plans to fund repurchases from three sources: cash provided by operating activities, short-term debt, and net cash proceeds from the Food Ingredients divestiture sale. The $500 million ASR in H2 2026 may utilize operating cash flow and short-term debt, while the remaining $2.0 billion is expected to be funded primarily from divestiture proceeds following the sale close.
How does the buyback fit into IFF's balance sheet strategy?: IFF intends to maintain a strong balance sheet with net leverage of 2.0x to 2.5x net debt to EBITDA. The company will prioritize debt reduction with over $1 billion of divestiture proceeds before allocating remaining proceeds to share repurchases. This two-pronged approach balances shareholder returns with financial flexibility and deleveraging from the company's current net debt position of approximately $5.2 billion as of June 30, 2026.
When will the full $2.5 billion repurchase be completed?: The $500 million ASR is planned for H2 2026. The remaining $2.0 billion will commence after the Food Ingredients divestiture closes, expected by end of Q2 2027, with the entire program targeted for completion by the end of 2027. The Board will review the program periodically and may adjust its term and size as needed.
What percentage of IFF's shares could be repurchased under this authorization?: Based on Q2 2026 average diluted shares outstanding of 257 million, the $2.5 billion program could retire approximately 1–2% of shares outstanding, depending on execution price and market conditions. The actual share reduction will depend on the average price paid per share during the execution period over the next 18 months.

authorization mega-cap asr specialty-chemicals food-fragrance divestiture-funded

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.